TG Therapeutics
TGTX
TGTX
213 hedge funds and large institutions have $1.42B invested in TG Therapeutics in 2023 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 61 increasing their positions, 61 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.6% more ownership
Funds ownership: 64.22% → 64.81% (+0.6%)
0% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 61
Holders
213
Holding in Top 10
4
Calls
$41.9M
Puts
$21.1M
Top Buyers
| 1 | +$157M | |
| 2 | +$76.7M | |
| 3 | +$16.5M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$15.1M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$12.8M |
Top Sellers
| 1 | -$53.6M | |
| 2 | -$51.1M | |
| 3 | -$41.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$31.9M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$30.3M |